Proactive Investors - Run By Investors For Investors

Medtech disruptor Lancor Scientific strengthens its marketing team

Lancor Scientific's CEO Aamir Butt and Head of Marketing & Global Access Dr. Donald De Korte tell Proactive London how the company is now poised, after 10 years of R&D, to deliver low cost cancer screening to millions.
Lancor recently gained permission to work in a cancer research laboratory in Austria and have made inroads into low income countries such as Zimbabwe, working in rural areas and taking their instant results cancer testing kit with them.
Dr. De Korte is a new addition to the Lancor team and Butt is thrilled to have that expertise on board as De Korte's experience in disease control in Sub-Saharan Africa is, he says, second to none.
Dr. De Korte also regards Lancor's fusion of blockchain technology and healthcare as nothing short of revolutionary, saying that blockchain "really puts the patient first".
He goes on to say...''I believe strongly that our technology and the way it's connected to blockchain will really revolutionise access to cancer screening and ultimately the appropriate management of cancer in the developing world''.

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here  
View full LANCO profile View Profile

Lancor Scientific Timeline

Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use